Comparative Pharmacology
Head-to-head clinical analysis: DIETHYLSTILBESTROL versus IMVEXXY.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIETHYLSTILBESTROL versus IMVEXXY.
DIETHYLSTILBESTROL vs IMVEXXY
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Synthetic nonsteroidal estrogen that binds to estrogen receptors (ERα/ERβ), activating estrogen-responsive gene transcription, leading to proliferation of estrogen-sensitive tissues.
Estradiol, a form of estrogen, binds to estrogen receptors (ERα and ERβ) in target tissues, modulating gene transcription and producing effects such as proliferation of the vaginal epithelium and increased cervical secretions, which relieve vulvar and vaginal atrophy symptoms.
0.5-2 mg orally once daily for palliative treatment of advanced prostate cancer; 5-15 mg orally once daily for prevention of postpartum breast engorgement.
IMVEXXY (estradiol vaginal insert) 10 mcg inserted vaginally once daily for 2 weeks, then twice weekly (e.g., Monday and Thursday).
None Documented
None Documented
Clinical Note
moderateDiethylstilbestrol + Digoxin
"Diethylstilbestrol may decrease the cardiotoxic activities of Digoxin."
Clinical Note
moderateDiethylstilbestrol + Digitoxin
"Diethylstilbestrol may decrease the cardiotoxic activities of Digitoxin."
Clinical Note
moderateDiethylstilbestrol + Deslanoside
"Diethylstilbestrol may decrease the cardiotoxic activities of Deslanoside."
Clinical Note
moderateDiethylstilbestrol + Acetyldigitoxin
Terminal elimination half-life is approximately 24 hours (range 20-30 hours) in adults; prolonged in hepatic impairment.
Terminal elimination half-life of estradiol is approximately 13-14 hours (range 10-16 hours) after vaginal administration, supporting once-daily dosing.
Primarily renal (90% as glucuronide and sulfate conjugates), with less than 5% excreted unchanged in urine; biliary/fecal elimination accounts for about 10%.
Primarily renal as glucuronide conjugates; approximately 30-50% of a dose is excreted in urine as estradiol metabolites, with ~10% excreted in feces via biliary elimination.
Category C
Category C
Estrogen
Estrogen
"Diethylstilbestrol may decrease the cardiotoxic activities of Acetyldigitoxin."